{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:16:12Z","timestamp":1790709372746,"version":"4.1.0"},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,9,1]]},"DOI":"10.2169\/internalmedicine.6679-20","type":"journal-article","created":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T22:06:38Z","timestamp":1614549998000},"page":"2839-2842","source":"Crossref","is-referenced-by-count":33,"title":["Successful Treatment of Mepolizumab- and Prednisolone-resistant Allergic Bronchopulmonary Aspergillosis with Dupilumab"],"prefix":"10.2169","volume":"60","author":[{"given":"Sunao","family":"Mikura","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Saraya","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miku","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Nakamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Takata","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shimoyamada","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kyorin University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masachika","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kyorin University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruyuki","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kyorin University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mussaffi H, Rivlin J, Shalit I, Ephros M, Blau H. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J 25: 324, 2005.","DOI":"10.1183\/09031936.05.00058604"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rabe KF, Nair P, Brusselle G, et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med 378: 2475, 2018.","DOI":"10.1056\/NEJMoa1804093"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ramonell RP, Lee FE, Swenson C, Kuruvilla M. Dupilumab treatment for allergic bronchopulmonary aspergillosis: a case series. J Allergy Clin Immunol Pract 8: 742, 2020.","DOI":"10.1016\/j.jaip.2019.11.031"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Agarwal R, Chakrabarti A, Shah A, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy 43: 850-873, 2013.","DOI":"10.1111\/cea.12141"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nair P, Wenzel S, Rabe KF, et al. Oral glucocorticoid-sparing effect of benralizumab in severe asthma. N Engl J Med 376: 2448, 2017.","DOI":"10.1056\/NEJMoa1703501"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 360: 985, 2009.","DOI":"10.1056\/NEJMoa0805435"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Li JX, Fan LC, Li MH, Cao WJ, Xu JF. Beneficial effects of omalizumab therapy in allergic bronchopulmonary aspergillosis: a synthesis review of published literature. Respir Med 122: 33, 2017.","DOI":"10.1016\/j.rmed.2016.11.019"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Becker KL, Gresnigt MS, Smeekens SP, et al. Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients. Clin Exp Allergy 45: 42, 2015.","DOI":"10.1111\/cea.12354"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Knutsen AP, Hutchinson PS, Albers GM, Consolino J, Smick J, Kurup VP. Increased sensitivity to IL-4 in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Allergy 59: 81, 2004.","DOI":"10.1046\/j.1398-9995.2003.00129.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Moss RB. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis. Ann NY Acad Sci 1272: 49, 2012.","DOI":"10.1111\/j.1749-6632.2012.06810.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Patel G, Pan J, Ye L, et al. Blockade of IL-4R\u03b1 inhibits group 2 innate lymphoid cell responses in asthma patients. Clin Exp Allergy 50: 267, 2020.","DOI":"10.1111\/cea.13514"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/17\/60_6679-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T03:23:13Z","timestamp":1630725793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/17\/60_6679-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":11,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6679-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"article-number":"6679-20"}}